If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Related content
Volume 9, Number 3, July 2010

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

Commentary (Research Highlights)
pp. 257-257(1)
Author: D. Skaper, Stephen

Favourites:Add to Favourites

The Role of Autophagy: What can be Learned from the Genetic Forms of Amyotrophic Lateral Sclerosis
pp. 268-278(11)
Authors: Pasquali, Livia; Ruffoli, Riccardo; Fulceri, Federica; Pietracupa, Sara; Siciliano, Gabriele; Paparelli, Antonio; Fornai, Francesco

Favourites:Add to Favourites

Histone Deacetylation and Motor Neuron Degeneration
pp. 279-284(6)
Authors: Schmalbach, S.; Petri, S.

Favourites:Add to Favourites

Protein Aggregation and Defective RNA Metabolism as Mechanisms for Motor Neuron Damage
pp. 285-296(12)
Authors: Ticozzi, N.; Ratti, A.; Silani, V.

Favourites:Add to Favourites

Amyotrophic Lateral Sclerosis and Excitotoxicity: From Pathological Mechanism to Therapeutic Target
pp. 297-304(8)
Authors: Bogaert, E.; d'Ydewalle, C.; Van Den Bosch, L.

Favourites:Add to Favourites

Clinical Trials for Neuroprotection in ALS
pp. 305-313(9)
Authors: Siciliano, G.; Carlesi, C.; Pasquali, L.; Piazza, S.; Pietracupa, S.; Fornai, F.; Ruggieri, S.; Murri, L.

Favourites:Add to Favourites

Stem Cells in Amyotrophic Lateral Sclerosis: Motor Neuron Protection or Replacement?
pp. 314-324(11)
Authors: Silani, V.; Calzarossa, C.; Cova, L.; Ticozzi, N.

Favourites:Add to Favourites
Favourites:Add to Favourites

Repetitive Transcranial Magnetic Stimulation for ALS
pp. 331-334(4)
Authors: Dileone, M.; Profice, P.; Pilato, F.; Ranieri, F.; Capone, F.; Musumeci, G.; Florio, L.; Di Iorio, R.; Di Lazzaro, V.

Favourites:Add to Favourites

Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets
pp. 335-348(14)
Authors: Schmidt, A.L.; Brunetto, A.L.; Schwartsmann, G.; Roesler, R.; Abujamra, A.L.

Favourites:Add to Favourites

Glia as a Turning Point in the Therapeutic Strategy of Parkinson's Disease
pp. 349-372(24)
Authors: L'Episcopo, Francesca; Tirolo, Cataldo; Testa, Nuccio; Caniglia, Salvo; Concetta Morale, Maria; Marchetti, Bianca

Favourites:Add to Favourites

Mechanisms of Oxidative Glutamate Toxicity: The Glutamate/Cystine Antiporter System xc¯ as a Neuroprotective Drug Target
pp. 373-382(10)
Authors: Albrecht, Philipp; Lewerenz, Jan; Dittmer, Sonja; Noack, Rebecca; Maher, Pamela; Methner, Axel

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more